11hOpinion
Storytelling in the age of data
In times when knowledge is stored and remixed as data, the tradition of storytelling still holds its own. The use of ...
ByteDance's drug unit showed an AI-designed IL-17 inhibitor at a Boston conference. The molecule targets interactions pharma called undruggable. Only trials will tell.
New strategic frameworks are emerging to help industries move AI adoption beyond isolated pilots, with engineering and asset management leaders rethinking workflows, talent, and operating models.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results